Dendritic cells in cardiovascular diseases: epiphenomenon, contributor, or therapeutic opportunity.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Circulation

• Publication date

  2013-12-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.113.003364PMID 24344059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?

  2013cited by this paper
• Immune responses elicited by apoB-100-derived peptides in mice

  2013cited by this paper
• National Trends in Heart Failure Hospitalization After Acute Myocardial Infarction for Medicare Beneficiaries: 1998–2010

  2013cited by this paper
• Identifying the risk and preventing the consequences of cardiovascular disease.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Immune mechanisms in angiotensin II-induced target-organ damage

  2012influential reference
• Faculty of 1000 evaluation for Deciphering the transcriptional network of the dendritic cell lineage.

  2012cited by this paper
• Transient reduction and activation of circulating dendritic cells in patients with acute myocardial infarction

  2012cited by this paper
• Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction.

  2012cited by this paper
• Auto-Antigenic Protein-DNA Complexes Stimulate Plasmacytoid Dendritic Cells to Promote Atherosclerosis

  2012cited by this paper
• Immune mechanisms of stroke.

  2012cited by this paper
• Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease

  2012cited by this paper
• Re(de)fining the dendritic cell lineage

  2012cited by this paper
• Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans.

  2012cited by this paper
• Deciphering the transcriptional network of the DC lineage

  2012cited by this paper
• oxLDL Downregulates the Dendritic Cell Homing Factors CCR7 and CCL21

  2012cited by this paper
• Plasmacytoid Dendritic Cells Play a Key Role in Promoting Atherosclerosis in Apolipoprotein E–Deficient Mice

  2012cited by this paper
• Inflammation in Myocardial Diseases

  2012cited by this paper
• Transient reduction and activation of circulating dendritic cells in patients with acute myocardial infarction.

  2012cited by this paper
• Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction.

  2012cited by this paper
• Circulating dendritic cell number and intracellular TNF-α production in women with type 2 diabetes

  2012cited by this paper
• Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function.

  2011cited by this paper
• Reduction and activation of circulating dendritic cells in patients with decompensated heart failure.

  2011cited by this paper
• Plasmacytoid Dendritic Cells Protect Against Atherosclerosis by Tuning T-Cell Proliferation and Activity

  2011cited by this paper
• Flt3 signaling-dependent dendritic cells protect against atherosclerosis.

  2011cited by this paper
• Dendritic Cells in Human Atherosclerosis: From Circulation to Atherosclerotic Plaques

  2011cited by this paper
• Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report

  2011cited by this paper
• S100A9 Differentially Modifies Phenotypic States of Neutrophils, Macrophages, and Dendritic Cells: Implications for Atherosclerosis and Adipose Tissue Inflammation

  2011cited by this paper
• Immunotherapy With Tolerogenic Apolipoprotein B-100–Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic Mice

  2011cited by this paper
• Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations.

  2011cited by this paper
• Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.

  2011cited by this paper
• Vaccination strategies in atherosclerosis

  2011cited by this paper
• Cyclooxygenase Inhibitors, Aspirin and Ibuprofen, Inhibit MHC-restricted Antigen Presentation in Dendritic Cells

  2010cited by this paper
• Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance

  2010cited by this paper
• Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.

  2010cited by this paper
• Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function

  2010cited by this paper
• Cardiovascular risk prediction: basic concepts, current status, and future directions.

  2010cited by this paper
• Resident Intimal Dendritic Cells Accumulate Lipid and Contribute to the Initiation of Atherosclerosis

  2010cited by this paper
• Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets

  2010cited by this paper
• Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention.

  2010cited by this paper
• Ontogeny and homeostasis of Langerhans cells

  2010cited by this paper
• Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.

  2010cited by this paper
• Regulation of plasmacytoid dendritic cell development.

  2010cited by this paper
• Inhibition and Genetic Ablation of the B7/CD28 T-Cell Costimulation Axis Prevents Experimental Hypertension

  2010cited by this paper
• Origin and development of dendritic cells

  2010cited by this paper
• Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease.

  2009cited by this paper
• Harms and benefits of lymphocyte subpopulations in patients with acute stroke.

  2009cited by this paper
• In Vivo Analysis of Dendritic Cell Development and Homeostasis

  2009cited by this paper
• Origins and tissue‐context‐dependent fates of blood monocytes

  2009cited by this paper
• Conventional Dendritic Cells at the Crossroads Between Immunity and Cholesterol Homeostasis in Atherosclerosis

  2009cited by this paper
• Abstract 5504: Transient Decrease in Circulating Dendritic Cell Precursors After Acute Stroke - Potential Recruitment Into the Brain

  2009cited by this paper
• Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy.

  2009cited by this paper
• Survival and Cardiac Remodeling After Myocardial Infarction Are Critically Dependent on the Host Innate Immune Interleukin-1 Receptor–Associated Kinase-4 Signaling: A Regulator of Bone Marrow–Derived Dendritic Cells

  2009cited by this paper
• Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.

  2009cited by this paper
• Graft-infiltrating dendritic cells and coronary endothelial dysfunction after human heart transplantation.

  2008cited by this paper
• Migration of dendritic cell subsets and their precursors.

  2008cited by this paper
• Effective Chemokine Secretion by Dendritic Cells and Expansion of Cross-Presenting CD4−/CD8+ Dendritic Cells Define a Protective Phenotype in the Mouse Model of Coxsackievirus Myocarditis

  2008cited by this paper
• Impact of innate and adaptive immunity on rejection and tolerance.

  2008cited by this paper
• Molecular biology and pathogenesis of viral myocarditis.

  2008cited by this paper
• Antigen-presentation properties of plasmacytoid dendritic cells.

  2008cited by this paper
• Early use of beta-blockers attenuates systemic inflammatory response and lung oxygenation impairment after distal type acute aortic dissection

  2008cited by this paper
• Time to foster a rational approach to preventing cardiovascular morbid events.

  2008cited by this paper
• CD11c+ Dendritic Cells Maintain Antigen Processing, Presentation Capabilities, and CD4+ T-Cell Priming Efficacy Under Hypercholesterolemic Conditions Associated With Atherosclerosis

  2008cited by this paper
• Toll‐like receptor‐4 and mitogen‐activated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome

  2008cited by this paper
• The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models

  2008cited by this paper
• Reduced frequency of peripheral dendritic cells in type 2 diabetes.

  2008cited by this paper
• Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension

  2007cited by this paper
• Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction

  2007cited by this paper
• Dyslipidemia inhibits Toll-like receptor–induced activation of CD8α-negative dendritic cells and protective Th1 type immunity

  2007cited by this paper
• [Hyperinsulinemia induced immune maturation of human monocyte derived dendritic cells: bridging between diabetes and atherosclerosis].

  2007cited by this paper
• Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease.

  2007cited by this paper
• Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo

  2007cited by this paper
• Tolerogenic dendritic cells and the quest for transplant tolerance

  2007cited by this paper
• Steady-state and inflammatory dendritic-cell development

  2007cited by this paper
• Peripheral-blood dendritic cells in men with coronary heart disease.

  2007cited by this paper
• Plasmacytoid T Cells Immunohistochemical Evidence for Their Monocyte/Macrophage Origin

  2007cited by this paper
• Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications.

  2007cited by this paper
• Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo

  2007cited by this paper
• Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro

  2007cited by this paper
• Monocytes give rise to mucosal, but not splenic, conventional dendritic cells

  2007cited by this paper
• Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts

  2006cited by this paper
• Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease

  2006cited by this paper
• Decrease in circulating myeloid dendritic cell precursors in coronary artery disease.

  2006cited by this paper
• Current State and Perspectives of Dendritic Cell Vaccination in Cancer Immunotherapy

  2006cited by this paper
• A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells

  2006cited by this paper
• Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis

  2006cited by this paper
• Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation1

  2006cited by this paper
• Pathogen-Sensing Plasmacytoid Dendritic Cells Stimulate Cytotoxic T-Cell Function in the Atherosclerotic Plaque Through Interferon-&agr;

  2006cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3–Induced Myocarditis and Influences Type I Interferon Production

  2005cited by this paper
• Advanced Glycosylation End Products Might Promote Atherosclerosis Through Inducing the Immune Maturation of Dendritic Cells

  2005cited by this paper
• Dendritic cells in atherosclerosis: current status of the problem and clinical relevance.

  2005cited by this paper
• Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy.

  2005cited by this paper
• Promotion of long-term heart allograft survival by combination of mobilized donor plasmacytoid dendritic cells and anti-CD154 monoclonal antibody.

  2005cited by this paper
• IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.

  2005cited by this paper
• Histological analysis of CD11c‐DTR/GFP mice after in vivo depletion of dendritic cells

  2005cited by this paper
• Oxidized Phospholipids Negatively Regulate Dendritic Cell Maturation Induced by TLRs and CD401

  2005cited by this paper
• Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin.

  2004cited by this paper
• Plasmacytoid dendritic cells in immunity

  2004cited by this paper
• Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses

  2004cited by this paper

• Intersecting epidemics: immune dysregulation associated with HIV and tuberculosis syndemic contribute to increased risk of hypertensive disease in Sub-Saharan Africa

  2025cites this paper
• Estrogen and Estrogen Receptors in Cardioimmunology: Implications in Physiology, Pathophysiology, and Therapeutic Strategies

  2025cites this paper
• Engineered immune-driven theranostics for clinical cardiology

  2025cites this paper
• Dendritic Cells: A Bridge between Tolerance Induction and Cancer Development in Transplantation Setting

  2024cites this paper
• Combining Polygenic and Proteomic Risk Scores With Clinical Risk Factors to Improve Performance for Diagnosing Absence of Coronary Artery Disease in Patients With de novo Chest Pain

  2023cites this paper
• Immune cells drive new immunomodulatory therapies for myocardial infarction: From basic to clinical translation

  2023cites this paper
• The Role of Innate Immune Cells in Cardiac Injury and Repair: A Metabolic Perspective

  2023cites this paper
• Inflammatory Cells in Atherosclerosis

  2022cites this paper
• Distribution and maturation state of peripheral blood dendritic cells in children with primary hypertension

  2021cites this paper
• A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases

  2021cites this paper
• Unraveling the thread of uncontrolled immune response in COVID-19 and STEMI: an emerging need for knowledge sharing

  2021cites this paper
• Tolerogenic dendritic cells induced by atorvastatin via inhibition of the TLR-4/NF-κB pathway improve cardiac remodeling after myocardial infarction

  2020cites this paper
• Depletion of CD11c+ dendritic cells in apolipoprotein E-deficient mice limits angiotensin II-induced abdominal aortic aneurysm formation and growth.

  2019cites this paper
• Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials

  2018cites this paper
• Mechanical stretch on endothelial cells interconnects innate and adaptive immune response in hypertension.

  2018cites this paper
• In vitro maturation of monocyte‐derived dendritic cells results in two populations of cells with different surface marker expression, independently of applied concentration of interleukin‐4

  2018cites this paper
• Blueberry supplementation attenuates oxidative stress within monocytes and modulates immune cell levels in adults with metabolic syndrome: a randomized, double-blind, placebo-controlled trial.

  2017cites this paper
• Partitioning the heritability of coronary artery disease highlights the importance of immune-mediated processes and epigenetic sites associated with transcriptional activity

  2017cites this paper
• Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension.

  2017cites this paper
• S100A1 from Damaged Cardiomyocytes Elicits a Chemoattractant Cardiac Fibroblast Phenotype

  2017cites this paper
• The role of FPR2/ALX in the vascular wall

  2015cites this paper
• Vascular Changes in the Microcirculation: Arterial Remodeling and Capillary Rarefaction

  2015cites this paper
• Self-Assembled DNA Immunonanoflowers as Multivalent CpG Nanoagents

  2015cites this paper
• Plasmacytoid dendritic cells in atherosclerosis: knocking at T-cell's door.

  2014cites this paper
• Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets

  2014cites this paper
• Innate immunity in atherosclerosis : the role of pattern recognition receptors

  2014cites this paper
• Dendritic cells in hyperlipidemia-associated atherosclerosis

  2013cites this paper